IL17A and tuberous sclerosis: Previous studies have revealed that many proinflammatory cytokines are upregulated in epileptogenic lesions and play pivotal roles in the epileptogenesis of FCD IIb and TSC patients, including IL1-β, IL-6, and IL-17 [15–17, 30].